NO - I don't think that is correct. ---- (and I am happy to be corrected)
The bulk of the CR was $5m.
Those shares were issued on 30 April 2024.
The balance of $500k was to BL, and had to be approved by s/h.
It was, and the shares (38 m shares) to BL were issued about 22 July 2024.
So the $4.972m of capital shown in the Qtrly must represent the $5m CR to those s/h other than BL.
So the balance of cash at end of June Qtr of $2.028m is AFTER the bulk of the CR.
So not so good. They will get BL's $500k.
I do not like the idea of IXR having to sell its s/h in VMM. We have no idea of how much tax rebate IXR will get from R&D grant? Is that Aust rebate of UK??? In Aust you can get funding based on security of the Tax R&D Rebate - but it would need to be confirmed that it would be paid by Govt eventually.
I reckon a CR is a certainty this Qtr - but I am hopeful IXR is awaiting some really positive news on Belfast, or even from Makuutu before it does any CR. All we need is a Offtake from either Makuutu of Belfast.
- Forums
- ASX - By Stock
- IXR
- Ann: June Quarterly Report
Ann: June Quarterly Report, page-18
Featured News
Add IXR (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.0¢ |
Change
-0.001(9.09%) |
Mkt cap ! $48.69M |
Open | High | Low | Value | Volume |
1.1¢ | 1.1¢ | 0.9¢ | $92.74K | 9.236M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
30 | 6611495 | 0.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.0¢ | 597231 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
30 | 6611495 | 0.009 |
20 | 3797977 | 0.008 |
21 | 10537518 | 0.007 |
16 | 11484499 | 0.006 |
27 | 6946373 | 0.005 |
Price($) | Vol. | No. |
---|---|---|
0.010 | 597231 | 1 |
0.011 | 4745949 | 11 |
0.012 | 2842609 | 10 |
0.013 | 2747059 | 6 |
0.014 | 1992885 | 6 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
IXR (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online